Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G

Kristine M. Rose, Mariana Marin, Susan L. Kozak, David Kabat

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

APOBEC3G and 3F (A3G and A3F) cytidine deaminases incorporate into retroviral cores where they lethally hypermutate nascent DNA reverse transcripts. As substantiated here, the viral infectivity factor (Vif) encoded by human immunodeficiency virus type-1 (HIV-1) binds A3G and A3F and induces their degradation, thereby precluding their incorporation into viral progeny. Previous evidence suggested that A3G is expressed in H9 and other nonpermissive cells that contain this antiviral defense but not in several permissive cells, and that overexpression of A3G or A3F makes permissive cells nonpermissive. Using a broader panel of cell lines, we confirmed a correlation between A3G and cellular abilities to inactivate HTV-1 (Δvif). However, there was a quantitative discrepancy because several cells with weak antiviral activities had similar amounts of wild-type A3G mRNA and protein compared to H9 cells. Antiviral activity of H9 cells was also attenuated in some conditions. These quantitative discrepancies could not be explained by the presence of A3F or other A3G paralogs in some of the cell lines. Thus, A3A, A3B, and A3C had weak but significant anti-HIV-1 activities and did not dominantly interfere with A3G or A3F antiviral functions. Control of A3G synthesis by the protein kinase C/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway was also similar in permissive and nonpermissive cells. A3G in highly permissive cells is degraded by Vif, suggesting that it is not in a sequestered site, and is specifically incorporated in low amounts into HIV-1 (Δvif). Although A3G and/or A3F inactivate HIV-1 (Δvif) and are neutralized by Vif, the antiviral properties of cell lines are also influenced by other cellular and viral factors.

Original languageEnglish (US)
Pages (from-to)611-619
Number of pages9
JournalAIDS Research and Human Retroviruses
Volume21
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

Cytidine Deaminase
HIV-1
Antiviral Agents
Cell Line
MAP Kinase Kinase Kinases
Extracellular Signal-Regulated MAP Kinases
Protein Kinase C
Messenger RNA
DNA

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G. / Rose, Kristine M.; Marin, Mariana; Kozak, Susan L.; Kabat, David.

In: AIDS Research and Human Retroviruses, Vol. 21, No. 7, 07.2005, p. 611-619.

Research output: Contribution to journalArticle

Rose, Kristine M. ; Marin, Mariana ; Kozak, Susan L. ; Kabat, David. / Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G. In: AIDS Research and Human Retroviruses. 2005 ; Vol. 21, No. 7. pp. 611-619.
@article{dd33dee854db486c995440a97fa5403d,
title = "Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G",
abstract = "APOBEC3G and 3F (A3G and A3F) cytidine deaminases incorporate into retroviral cores where they lethally hypermutate nascent DNA reverse transcripts. As substantiated here, the viral infectivity factor (Vif) encoded by human immunodeficiency virus type-1 (HIV-1) binds A3G and A3F and induces their degradation, thereby precluding their incorporation into viral progeny. Previous evidence suggested that A3G is expressed in H9 and other nonpermissive cells that contain this antiviral defense but not in several permissive cells, and that overexpression of A3G or A3F makes permissive cells nonpermissive. Using a broader panel of cell lines, we confirmed a correlation between A3G and cellular abilities to inactivate HTV-1 (Δvif). However, there was a quantitative discrepancy because several cells with weak antiviral activities had similar amounts of wild-type A3G mRNA and protein compared to H9 cells. Antiviral activity of H9 cells was also attenuated in some conditions. These quantitative discrepancies could not be explained by the presence of A3F or other A3G paralogs in some of the cell lines. Thus, A3A, A3B, and A3C had weak but significant anti-HIV-1 activities and did not dominantly interfere with A3G or A3F antiviral functions. Control of A3G synthesis by the protein kinase C/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway was also similar in permissive and nonpermissive cells. A3G in highly permissive cells is degraded by Vif, suggesting that it is not in a sequestered site, and is specifically incorporated in low amounts into HIV-1 (Δvif). Although A3G and/or A3F inactivate HIV-1 (Δvif) and are neutralized by Vif, the antiviral properties of cell lines are also influenced by other cellular and viral factors.",
author = "Rose, {Kristine M.} and Mariana Marin and Kozak, {Susan L.} and David Kabat",
year = "2005",
month = "7",
doi = "10.1089/aid.2005.21.611",
language = "English (US)",
volume = "21",
pages = "611--619",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G

AU - Rose, Kristine M.

AU - Marin, Mariana

AU - Kozak, Susan L.

AU - Kabat, David

PY - 2005/7

Y1 - 2005/7

N2 - APOBEC3G and 3F (A3G and A3F) cytidine deaminases incorporate into retroviral cores where they lethally hypermutate nascent DNA reverse transcripts. As substantiated here, the viral infectivity factor (Vif) encoded by human immunodeficiency virus type-1 (HIV-1) binds A3G and A3F and induces their degradation, thereby precluding their incorporation into viral progeny. Previous evidence suggested that A3G is expressed in H9 and other nonpermissive cells that contain this antiviral defense but not in several permissive cells, and that overexpression of A3G or A3F makes permissive cells nonpermissive. Using a broader panel of cell lines, we confirmed a correlation between A3G and cellular abilities to inactivate HTV-1 (Δvif). However, there was a quantitative discrepancy because several cells with weak antiviral activities had similar amounts of wild-type A3G mRNA and protein compared to H9 cells. Antiviral activity of H9 cells was also attenuated in some conditions. These quantitative discrepancies could not be explained by the presence of A3F or other A3G paralogs in some of the cell lines. Thus, A3A, A3B, and A3C had weak but significant anti-HIV-1 activities and did not dominantly interfere with A3G or A3F antiviral functions. Control of A3G synthesis by the protein kinase C/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway was also similar in permissive and nonpermissive cells. A3G in highly permissive cells is degraded by Vif, suggesting that it is not in a sequestered site, and is specifically incorporated in low amounts into HIV-1 (Δvif). Although A3G and/or A3F inactivate HIV-1 (Δvif) and are neutralized by Vif, the antiviral properties of cell lines are also influenced by other cellular and viral factors.

AB - APOBEC3G and 3F (A3G and A3F) cytidine deaminases incorporate into retroviral cores where they lethally hypermutate nascent DNA reverse transcripts. As substantiated here, the viral infectivity factor (Vif) encoded by human immunodeficiency virus type-1 (HIV-1) binds A3G and A3F and induces their degradation, thereby precluding their incorporation into viral progeny. Previous evidence suggested that A3G is expressed in H9 and other nonpermissive cells that contain this antiviral defense but not in several permissive cells, and that overexpression of A3G or A3F makes permissive cells nonpermissive. Using a broader panel of cell lines, we confirmed a correlation between A3G and cellular abilities to inactivate HTV-1 (Δvif). However, there was a quantitative discrepancy because several cells with weak antiviral activities had similar amounts of wild-type A3G mRNA and protein compared to H9 cells. Antiviral activity of H9 cells was also attenuated in some conditions. These quantitative discrepancies could not be explained by the presence of A3F or other A3G paralogs in some of the cell lines. Thus, A3A, A3B, and A3C had weak but significant anti-HIV-1 activities and did not dominantly interfere with A3G or A3F antiviral functions. Control of A3G synthesis by the protein kinase C/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway was also similar in permissive and nonpermissive cells. A3G in highly permissive cells is degraded by Vif, suggesting that it is not in a sequestered site, and is specifically incorporated in low amounts into HIV-1 (Δvif). Although A3G and/or A3F inactivate HIV-1 (Δvif) and are neutralized by Vif, the antiviral properties of cell lines are also influenced by other cellular and viral factors.

UR - http://www.scopus.com/inward/record.url?scp=23444450544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444450544&partnerID=8YFLogxK

U2 - 10.1089/aid.2005.21.611

DO - 10.1089/aid.2005.21.611

M3 - Article

VL - 21

SP - 611

EP - 619

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 7

ER -